Clinical Feature and Treatment of Microsporidial Keratoconjunctivitis
NCT03555409 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2018-06-15
Summary
The purpose of this project was to analysis the causes, pathogenesis, diagnostic modalities and treatment outcomes of microsporidial keratoconjunctivitis.
Conditions
- Microsporidial Keratoconjunctivitis
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
I-Jong Wang · National Taiwan University Hospital
Eligibility
- Min Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2019-05-31
- Completion
- 2019-05-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Diadenosine Polyphosphates and Mucin Associated With Ocular Surface Disorders
NCT03731624 ·Status: UNKNOWN
-
The Role of Cytokines and Mast Cell in the Pathogenesis of SLK, Conjunctivochalasis, and Dry Eye
NCT02160327 ·Status: UNKNOWN
-
The Pathogenesis of Superior Limbic Keratoconjunctivitis
NCT00167050 ·Status: UNKNOWN
-
Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome
NCT02774707 ·Status: UNKNOWN
-
Identification and Validation of Functional Biomarkers for Keratoconus
NCT01746823 ·Status: UNKNOWN
-
Evaluation and Treatment of Patients With Corneal and External Diseases
NCT00008541 ·Status: COMPLETED
-
Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment of Dry Eye Disease
NCT07298811 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
NCT05322148 ·Status: COMPLETED ·Phase: PHASE3
-
Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
NCT00426023 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Tacrolimus in Vernal Keratoconjunctivitis
NCT02456025 ·Status: UNKNOWN ·Phase: PHASE4
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
NCT01679015 ·Status: COMPLETED
-
The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression
NCT05713981 ·Status: COMPLETED ·Phase: NA
-
Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
NCT02199327 ·Status: COMPLETED ·Phase: PHASE4
-
TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
NCT00848198 ·Status: COMPLETED
-
The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic Conjunctivitis
NCT05839938 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients
NCT02712762 ·Status: COMPLETED
-
China Red Eye Study on Allergic Conjunctivitis
NCT03812952 ·Status: UNKNOWN
-
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503189 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis
NCT04085016 ·Status: COMPLETED
-
Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis
NCT00884585 ·Status: COMPLETED ·Phase: PHASE3
-
The Proportion of Patients Diagnosed With Dry Eye by the Asia Dry Eye Society (ADES) Criteria in Taiwan (DECS-TW)
NCT05096546 ·Status: UNKNOWN
-
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT00349466 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
NCT03216096 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
NCT04296864 ·Status: RECRUITING ·Phase: PHASE2